Company intelligence / Profile preview

Ant Group

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Ant Group’s AI healthcare platform “AQ” connects users to over 5,000 hospitals and 1 million doctors; it reached 140 million users within months of its 2025 launch, focusing on digital triage, medical report interpretation, and patient education, especially in lower-tier Chinese cities.

Therapeutic areas: OncologyOtherEndocrinology
Modalities: DeviceAI-powered medical softwareDigital health platforms
Industry: Digital Health Medical Devices

Partnerships

Peking University Third Hospital (AI Healthcare Lab)Renji HospitalBeijing Friendship Hospital

Beyond the preview

Go deeper on Ant Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ant Group.

Explore the full profile